http://inspra.legalview.com/msn/ 2012-02-23 http://inspra.legalview.com/msn/nice-recommends-insprar-eplerenone-for-the-treatment-of-post-mi-heart/1233230/ 2012-02-23 http://inspra.legalview.com/msn/bristol-pfizer-halt-anti-clotting-drug-trial-on-signal-of-benefit/1195174/ 2012-02-23 http://inspra.legalview.com/msn/us-stocks-wall-st-up-2-pct-on-china-comments-microsoft-upgrade/1195173/ 2012-02-23 http://inspra.legalview.com/msn/inspra-a-cost-effective-when-added-to-current-standard-care-for-post/1195172/ 2012-02-23 http://inspra.legalview.com/msn/recent-comments/1102773/ 2012-02-23 http://inspra.legalview.com/msn/sinobiopharma-secures-rights-to-seven-key-patents/1102772/ 2012-02-23 http://inspra.legalview.com/msn/ipauctions-inc-to-sell-six-medical-patent-applications-on-behalf-of/1102771/ 2012-02-23 http://inspra.legalview.com/msn/pfizers-funk/1102770/ 2012-02-23 http://inspra.legalview.com/msn/us-fda-advisory-meetings-through-aug-13/1102769/ 2012-02-23 http://inspra.legalview.com/msn/women-with-heart-failure-may-respond-to-different-therapies/1102768/ 2012-02-23 http://inspra.legalview.com/msn/in-our-towns-d300-racks-up-awards/1102767/ 2012-02-23